Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Nivolumab – Benefit assessment according to §35a Social Code Book V; Dossier assessment; Commission A15-27. October 13, 2015. (IQWiG reports; Volume 331).
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Nivolumab – Addendum to Commission A15-27; Commission A15-50. December 11, 2015. (IQWiG reports; Volume 346).
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Nivolumab (new therapeutic indication) – Benefit assessment according to §35a Social Code Book V; Dossier assessment; Commission A16-35. September 12, 2016. (IQWiG reports; Volume 432).
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Nivolumab (melanoma) – Addendum to Commission A16-35; Commission A16-68. November 21, 2016. (IQWiG reports; Volume 465).
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Nivolumab (melanoma) – Benefit assessment according to §35a Social Code Book V; Dossier assessment; Commission A17-27. September 13, 2017. (IQWiG reports; Volume 540).
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Nivolumab (melanoma) – Benefit assessment according to §35a Social Code Book V (expiry of the decision); Dossier assessment; Commission A18-40. September 13, 2018. (IQWiG reports; Volume 665).
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Nivolumab (melanoma) – Benefit assessment according to §35a Social Code Book V; Dossier assessment; Commission A18-53. November 29, 2018. (IQWiG reports; Volume 684).
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.